CAI - NASDAQ

Caris Life Sciences, Inc.

CAI·NASDAQ

$15.48

+9.9%

HealthcareBiotechnology

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$4.38B

EPS-1.9000

P/E Ratio-83.86

Earnings Date08/11/2026

cai

Other Current Assets

Last Annual Value

85.57M

3-Year CAGR

144%

5-Year CAGR

-22%

10-Year CAGR

39%

Adjust for Inflation

Caris Life Sciences, Inc. Competitors Analysis of Other Current Assets

CAI · NASDAQ

Company	Other Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Caris Life Sciences, Inc. NASDAQ:CAI	85.57M	158.3%	N/A	N/A
Moderna, Inc. NASDAQ:MRNA	408.00M	66.7%	73.4%	N/A
Atrium Therapeutics, Inc. NASDAQ:RNA	1.31M	N/A	N/A	N/A
Cytokinetics, Incorporated NASDAQ:CYTK	34.75M	N/A	N/A	N/A
Corcept Therapeutics Incorporated NASDAQ:CORT	40.66M	16.3%	35.5%	35.4%
Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL	52.89M	156.1%	N/A	N/A
Jazz Pharmaceuticals plc NASDAQ:JAZZ	476.44M	14.1%	13.5%	32.2%
Halozyme Therapeutics, Inc. NASDAQ:HALO	64.64M	10.0%	N/A	N/A
Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM	9.97M	14.3%	20.1%	46.7%

Caris Life Sciences, Inc. Fair Value Envelope

CAI · NASDAQ

Our analysis suggests that CAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $15.48, this represents a potential HIDDEN relative to our calculated worth for Caris Life Sciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $15.48

Related Guides

Blog Categories

Continue your CAI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.